Clinical trial
A Study of Pitolisant in Patients With Prader-Willi Syndrome
NCT06366464
Study timeline
Study start (actual)2024-05-28Date precision: day
Registry last updated2026-08-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prader-Willi Syndromeunresolved
Interventions
Placebo tabletOTHER
Sponsors & collaborators
Harmony Biosciences Management, Inc.lead sponsor
Mapped research locations
AtlantaGeorgia, United States3BucharestRomania3BaltimoreMaryland, United States2BarcelonaSpain2HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1TorontoOntario, Canada1San AntonioTexas, United States1MadridSpain1ClevelandOhio, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06366464 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.